EW:NYSE
Edwards Lifesciences Corp
$86.35
arrow_downward
-0.54%(-0.47) 1D
Sep 24, 2:49:15 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$86.54
High
$87.12
Low
$86.07
Mkt. cap
49.80B
Avg. vol.
3.05M
Volume
1.57M
P/E ratio
49.98
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.85
Shares outstanding
576.40M
No. of employees
16K
Open
$86.54
High
$87.12
Low
$86.07
Mkt. cap
49.80B
Avg. vol.
3.05M
Volume
1.57M
P/E ratio
49.98
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.85
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
AD HOC NEWS
·
3 days ago
Edwards Lifesciences stock holds steady after July-quarter earnings beat
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com